Text Education About Cardiovascular Health and HIV (TEACH-HIV)

a study on HIV/AIDS Immunodeficiency Cardiovascular Disease Atherosclerosis Peripheral Artery Disease

Summary

Eligibility
for people ages 40 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around
Principal Investigator
by Megan McLaughlin, MD, MPH
Headshot of Megan McLaughlin
Megan McLaughlin

Description

Summary

The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).

Keywords

HIV, Human Immunodeficiency Virus, Cardiovascular Diseases, Atherosclerosis, Acquired Immunodeficiency Syndrome, HIV Infections, Digital Educational Messaging

Eligibility

You can join if…

Open to people ages 40 years and up

  • HIV positive
  • At least 40 years of age
  • English-speaking

You CAN'T join if...

  • Existing clinical atherosclerotic cardiovascular disease (ASCVD)
  • Pregnant
  • Unwilling/unable to provide informed consent
  • Does not own a smartphone

Locations

  • Zuckerberg San Francisco General Hospital accepting new patients
    San Francisco California 94110 United States
  • UCSF accepting new patients
    San Francisco California 94115 United States

Lead Scientist at UCSF

  • Megan McLaughlin, MD, MPH
    Dr. McLaughlin is a general cardiologist trained in echocardiography (ultrasound of the heart). She has special interests in echocardiography, women’s cardiovascular health, and prevention of heart disease.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT05642858
Study Type
Interventional
Participants
Expecting 260 study participants
Last Updated
Contact us about this trial